<?xml version="1.0" encoding="UTF-8"?>
<p class="p">The need to regulate hypertension has led to the development of ACE inhibitors. To date, different classes of synthetic ACE inhibitors are available on the market, such as captopril, lisinopril, and enalapril. This class of drugs has demonstrated clinical efficacy in terms of treating hypertension and reducing mortality [
 <xref rid="B215-marinedrugs-17-00304" ref-type="bibr" class="xref">215</xref>,
 <xref rid="B216-marinedrugs-17-00304" ref-type="bibr" class="xref">216</xref>]. Although, treatments with ACE inhibitors have also been associated with unpleasant or intolerable side effects, including hypotension, angioedema, coughing, dizziness, headaches, nausea, and renal damage [
 <xref rid="B217-marinedrugs-17-00304" ref-type="bibr" class="xref">217</xref>]. Synthetic antihypertensive drugs also represent a major burden on global healthcare costs. Thus, there is great interest in the use of antihypertensive compounds from natural resources.
</p>
